ConductScience.org, home

Paper249793

Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.

Faville RJ and 5 others. JAMA, 1978. Cited by 167 papers, by iCite.

Cite this record

ConductScience Library. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. Papers, record 249793. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/249793

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin.
PubMed
Journal
JAMA
PubMed
Year
1978
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
167
iCite
Relative citation ratio, by iCite
7.86
iCite
Revised in PubMed
2019-06-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Faville RJ JrR J
2Zaske DED E
3Kaplan ELE L
4Crossley KK
5Sabath LDL D
6Quie PGP G

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Endocarditis, BacterialMajor topic
RifampinMajor topic
Staphylococcal InfectionsMajor topic
VancomycinMajor topic
Blood
Child, Preschool
Drug Therapy, Combination
Female
Humans
Infant
Male
Methicillin
Penicillin Resistance
Sepsis
Staphylococcus aureus

Source PubMed

Download CSV of topics

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.

PMIDTitleJournalYearIn PapersSource
30760474Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management.Clin Microbiol Rev2019https://conductscience.org/library/papers/30760474PubMed
24775563Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.BMC Infect Dis2014https://conductscience.org/library/papers/24775563PubMed
22553438Influence of rifampin therapy on serum bactericidal activity in the presence of cloxacillin and vancomycin.Can J Infect Dis1990https://conductscience.org/library/papers/22553438PubMed
21163725Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.Eur J Med Res2010https://conductscience.org/library/papers/21163725PubMed
18474578Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.Antimicrob Agents Chemother2008https://conductscience.org/library/papers/18474578PubMed
18159442The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.Can J Infect Dis2004https://conductscience.org/library/papers/18159442PubMed
17712583Rifampin as adjuvant treatment of Gram-positive bacterial infections: a systematic review of comparative clinical trials.Eur J Clin Microbiol Infect Dis2007https://conductscience.org/library/papers/17712583PubMed
15509186Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.Clin Pharmacokinet2004https://conductscience.org/library/papers/15509186PubMed
15388469In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15388469PubMed
15184410Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia.J Clin Microbiol2004https://conductscience.org/library/papers/15184410PubMed
12709345Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12709345PubMed
11959588Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/11959588PubMed
9371356
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9371356PubMed
9336672Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.Clin Microbiol Rev1997https://conductscience.org/library/papers/9336672PubMed
9174189Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174189PubMed
8285624Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8285624PubMed
8203842Role of tolerance in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis with vancomycin, teicoplanin, and daptomycin.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/8203842PubMed
7985998Teicoplanin alone or combined with rifampin compared with vancomycin for prophylaxis and treatment of experimental foreign body infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7985998PubMed
7486895Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7486895PubMed
7325636Characteristics of rifampin-resistant variants obtained from clinical isolates of Staphylococcus aureus.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7325636PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/249793

GET https://conductscience.org/api/papers/v1/249793/cited_by?page=2